Abstract
Target-focused compound libraries are collections of compounds which are designed to interact with an individual protein target or, frequently, a family of related targets (such as kinases, voltage-gated ion channels, serine/cysteine proteases). They are used for screening against therapeutic targets in order to find hit compounds that might be further developed into drugs. The design of such libraries generally utilizes structural information about the target or family of interest. In the absence of such structural information, a chemogenomic model that incorporates sequence and mutagenesis data to predict the properties of the binding site can be employed. A third option, usually pursued when no structural data are available, utilizes knowledge of the ligands of the target from which focused libraries can be developed via scaffold hopping. Consequently, the methods used for the design of target-focused libraries vary according to the quantity and quality of structural or ligand data that is available for each target family. This article describes examples of each of these design approaches and illustrates them with case studies, which highlight some of the issues and successes observed when screening target-focused libraries.
Keywords: Library design, target focus, kinase, ion channel, GPCR, PPI, HTS, hit rate, BioFocus, Galapagos, SoftFocus
Combinatorial Chemistry & High Throughput Screening
Title: The Design and Application of Target-Focused Compound Libraries
Volume: 14 Issue: 6
Author(s): C. John Harris, Richard D. Hill, David W. Sheppard*, Martin J. Slater and Pieter F.W. Stouten
Affiliation:
- ,0
Keywords: Library design, target focus, kinase, ion channel, GPCR, PPI, HTS, hit rate, BioFocus, Galapagos, SoftFocus
Abstract: Target-focused compound libraries are collections of compounds which are designed to interact with an individual protein target or, frequently, a family of related targets (such as kinases, voltage-gated ion channels, serine/cysteine proteases). They are used for screening against therapeutic targets in order to find hit compounds that might be further developed into drugs. The design of such libraries generally utilizes structural information about the target or family of interest. In the absence of such structural information, a chemogenomic model that incorporates sequence and mutagenesis data to predict the properties of the binding site can be employed. A third option, usually pursued when no structural data are available, utilizes knowledge of the ligands of the target from which focused libraries can be developed via scaffold hopping. Consequently, the methods used for the design of target-focused libraries vary according to the quantity and quality of structural or ligand data that is available for each target family. This article describes examples of each of these design approaches and illustrates them with case studies, which highlight some of the issues and successes observed when screening target-focused libraries.
Export Options
About this article
Cite this article as:
John Harris C., D. Hill Richard, W. Sheppard David*, J. Slater Martin and F.W. Stouten Pieter, The Design and Application of Target-Focused Compound Libraries, Combinatorial Chemistry & High Throughput Screening 2011; 14 (6) . https://dx.doi.org/10.2174/138620711795767802
DOI https://dx.doi.org/10.2174/138620711795767802 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis, Characterization, Biological Activity of Novel 1H-benzo[f]- chromene and 12H-benzo[f]chromeno[2,3-d]pyrimidine Derivatives
Letters in Drug Design & Discovery Hydroxychloroquine (HCQ) Exhibits Better Binding to the Main Protease (M<sup>pro</sup>) Compared to Spike Protein (S protein) of SARS-CoV-2: An In-silico Analysis
Clinical Cancer Drugs Review on Diagnostic Methods for SARS-CoV-2
Coronaviruses Pyrazole Schiff Base Hybrids as Anti-Malarial Agents: Synthesis, In Vitro Screening and Computational Study
Combinatorial Chemistry & High Throughput Screening Operationalized Psychodynamic Diagnosis
Adolescent Psychiatry Synthesis and Structure-Activity Relationship on Anticonvulsant Aryl Semicarbazones
Medicinal Chemistry WITHDRAWN: The Potential Role of Probiotics in the Management of COVID-19
Current Probiotics Green Synthesis of Copper Nanoparticles by Using Plant Extracts and their Biomedical Applications – An Extensive Review
Current Nanomaterials Design, Synthesis and Biological Evaluation of Some Novel Thiazole-2- Carboxamide Derivatives as Antitumor Agents
Letters in Drug Design & Discovery Challenges and Successes Using Nanomedicines for Aerosol Delivery to the Airways
Current Gene Therapy A Comprehensive Review on <i>In Silico</i>-predicted Potential Phytochemicals against SARS-CoV-2: Food for Thought for Researchers
Letters in Organic Chemistry Physiologically Based Pharmacokinetic Models: Integration of In Silico Approaches with Micro Cell Culture Analogues
Current Drug Metabolism Preface
Current Medicinal Chemistry Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives
Medicinal Chemistry A Review of COVID-19 Diagnostic Approaches in Computer Vision
Current Medical Imaging High Throughput Screen Identifies Natural Product Inhibitor of Phenylalanyl-tRNA Synthetase from Pseudomonas aeruginosa and Streptococcus pneumoniae
Current Drug Discovery Technologies Orally Administrated Small Molecule Drugs with Intestine Targeted Profile: Recent Development and Prospects
Current Medicinal Chemistry Herpesvirus Saimiri-Based Gene Delivery Vectors
Current Gene Therapy 4-Aminoquinazoline Analogs: A Novel Class of Anticancer Agents
Mini-Reviews in Medicinal Chemistry Luminescent G-quadruplex Probes
Current Pharmaceutical Design